21-45991017-T-C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001848.3(COL6A1):​c.1095T>C​(p.Gly365Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.551 in 1,612,982 control chromosomes in the GnomAD database, including 248,265 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.59 ( 27784 hom., cov: 33)
Exomes 𝑓: 0.55 ( 220481 hom. )

Consequence

COL6A1
NM_001848.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:13

Conservation

PhyloP100: -1.89

Publications

23 publications found
Variant links:
Genes affected
COL6A1 (HGNC:2211): (collagen type VI alpha 1 chain) The collagens are a superfamily of proteins that play a role in maintaining the integrity of various tissues. Collagens are extracellular matrix proteins and have a triple-helical domain as their common structural element. Collagen VI is a major structural component of microfibrils. The basic structural unit of collagen VI is a heterotrimer of the alpha1(VI), alpha2(VI), and alpha3(VI) chains. The alpha2(VI) and alpha3(VI) chains are encoded by the COL6A2 and COL6A3 genes, respectively. The protein encoded by this gene is the alpha 1 subunit of type VI collagen (alpha1(VI) chain). Mutations in the genes that code for the collagen VI subunits result in the autosomal dominant disorder, Bethlem myopathy. [provided by RefSeq, Jul 2008]
COL6A1 Gene-Disease associations (from GenCC):
  • collagen 6-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • Bethlem myopathy 1A
    Inheritance: AR, AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AD, AR Classification: STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 21-45991017-T-C is Benign according to our data. Variant chr21-45991017-T-C is described in ClinVar as Benign. ClinVar VariationId is 93805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.89 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.745 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A1NM_001848.3 linkc.1095T>C p.Gly365Gly synonymous_variant Exon 15 of 35 ENST00000361866.8 NP_001839.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A1ENST00000361866.8 linkc.1095T>C p.Gly365Gly synonymous_variant Exon 15 of 35 1 NM_001848.3 ENSP00000355180.3

Frequencies

GnomAD3 genomes
AF:
0.595
AC:
90329
AN:
151928
Hom.:
27743
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.752
Gnomad AMI
AF:
0.573
Gnomad AMR
AF:
0.519
Gnomad ASJ
AF:
0.585
Gnomad EAS
AF:
0.344
Gnomad SAS
AF:
0.512
Gnomad FIN
AF:
0.495
Gnomad MID
AF:
0.497
Gnomad NFE
AF:
0.558
Gnomad OTH
AF:
0.572
GnomAD2 exomes
AF:
0.523
AC:
130962
AN:
250540
AF XY:
0.522
show subpopulations
Gnomad AFR exome
AF:
0.756
Gnomad AMR exome
AF:
0.428
Gnomad ASJ exome
AF:
0.571
Gnomad EAS exome
AF:
0.348
Gnomad FIN exome
AF:
0.492
Gnomad NFE exome
AF:
0.550
Gnomad OTH exome
AF:
0.518
GnomAD4 exome
AF:
0.546
AC:
798217
AN:
1460936
Hom.:
220481
Cov.:
63
AF XY:
0.546
AC XY:
396517
AN XY:
726770
show subpopulations
African (AFR)
AF:
0.758
AC:
25372
AN:
33478
American (AMR)
AF:
0.435
AC:
19470
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.574
AC:
15007
AN:
26130
East Asian (EAS)
AF:
0.353
AC:
13997
AN:
39700
South Asian (SAS)
AF:
0.519
AC:
44742
AN:
86250
European-Finnish (FIN)
AF:
0.490
AC:
25831
AN:
52702
Middle Eastern (MID)
AF:
0.512
AC:
2949
AN:
5762
European-Non Finnish (NFE)
AF:
0.556
AC:
617765
AN:
1111818
Other (OTH)
AF:
0.548
AC:
33084
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
22415
44831
67246
89662
112077
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
17290
34580
51870
69160
86450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.595
AC:
90438
AN:
152046
Hom.:
27784
Cov.:
33
AF XY:
0.589
AC XY:
43760
AN XY:
74328
show subpopulations
African (AFR)
AF:
0.752
AC:
31222
AN:
41492
American (AMR)
AF:
0.519
AC:
7934
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.585
AC:
2026
AN:
3466
East Asian (EAS)
AF:
0.345
AC:
1775
AN:
5146
South Asian (SAS)
AF:
0.511
AC:
2469
AN:
4828
European-Finnish (FIN)
AF:
0.495
AC:
5239
AN:
10580
Middle Eastern (MID)
AF:
0.514
AC:
151
AN:
294
European-Non Finnish (NFE)
AF:
0.558
AC:
37894
AN:
67926
Other (OTH)
AF:
0.572
AC:
1208
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1853
3706
5558
7411
9264
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
746
1492
2238
2984
3730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.567
Hom.:
55418
Bravo
AF:
0.603
Asia WGS
AF:
0.449
AC:
1560
AN:
3478
EpiCase
AF:
0.551
EpiControl
AF:
0.551

ClinVar

Significance: Benign
Submissions summary: Benign:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:8
Jan 05, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Oct 14, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 04, 2021
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Bethlem myopathy 1A Benign:2
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Collagen 6-related myopathy Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Ullrich congenital muscular dystrophy 1A Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.13
DANN
Benign
0.35
PhyloP100
-1.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1980982; hg19: chr21-47410931; COSMIC: COSV62611847; COSMIC: COSV62611847; API